Analysis of the Binding Forces Driving the Tight Interactions between β-Lactamase Inhibitory Protein-II (BLIP-II) and Class A β-Lactamases

被引:18
作者
Brown, Nicholas G. [1 ,2 ]
Chow, Dar-Chone [2 ]
Sankaran, Banumathi [4 ]
Zwart, Peter [4 ]
Prasad, B. V. Venkataram [2 ,3 ]
Palzkill, Timothy [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[4] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
STAPHYLOCOCCUS-AUREUS PC1; SITE-DIRECTED MUTAGENESIS; ACYL-ENZYME INTERMEDIATE; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC STRUCTURE; MODULAR ARCHITECTURE; PHAGE DISPLAY; COMPLEX; INTERFACE; TEM-1;
D O I
10.1074/jbc.M111.265058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Lactamases hydrolyze beta-lactam antibiotics to provide drug resistance to bacteria. beta-Lactamase inhibitory protein-II (BLIP-II) is a potent proteinaceous inhibitor that exhibits low picomolar affinity for class A beta-lactamases. This study examines the driving forces for binding between BLIP-II and beta-lactamases using a combination of presteady state kinetics, isothermal titration calorimetry, and x-ray crystallography. The measured dissociation rate constants for BLIP-II and various beta-lactamases ranged from 10(-4) to 10(-7) s(-1) and are comparable with those found in some of the tightest known protein-protein interactions. The crystal structures of BLIP-II alone and in complex with Bacillus anthracis Bla1 beta-lactamase revealed no significant side-chain movement in BLIP-II in the complex versus the monomer. The structural rigidity of BLIP-II minimizes the loss of the entropy upon complex formation and, as indicated by thermodynamics experiments, may be a key determinant of the observed potent inhibition of beta-lactamases.
引用
收藏
页码:32723 / 32735
页数:13
相关论文
共 94 条
  • [1] ADACHI H, 1991, J BIOL CHEM, V266, P3186
  • [2] PHENIX:: building new software for automated crystallographic structure determination
    Adams, PD
    Grosse-Kunstleve, RW
    Hung, LW
    Ioerger, TR
    McCoy, AJ
    Moriarty, NW
    Read, RJ
    Sacchettini, JC
    Sauter, NK
    Terwilliger, TC
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 1948 - 1954
  • [3] Biophysical characterization of the interaction of the β-lactamase TEM-1 with its protein inhibitor BLIP
    Albeck, S
    Schreiber, G
    [J]. BIOCHEMISTRY, 1999, 38 (01) : 11 - 21
  • [4] Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamases
    Ali Shah, A
    Hasan, F
    Ahmed, S
    Hameed, A
    [J]. RESEARCH IN MICROBIOLOGY, 2004, 155 (06) : 409 - 421
  • [5] A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme
    Andújar-Sánchez, M
    Cámara-Artigas, A
    Jara-Pérez, V
    [J]. BIOPHYSICAL CHEMISTRY, 2004, 111 (02) : 183 - 189
  • [6] [Anonymous], 2002, PYMOL MOL GRAPHICS S
  • [7] NCI: a server to identify non-canonical interactions in protein structures
    Babu, MM
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (13) : 3345 - 3348
  • [8] Predicting kinetic constants of protein-protein interactions based on structural properties
    Bai, Hongjun
    Yang, Kun
    Yu, Daqi
    Zhang, Changsheng
    Chen, Fangjin
    Lai, Luhua
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2011, 79 (03) : 720 - 734
  • [9] CENTA as a chromogenic substrate for studying β-lactamases
    Bebrone, C
    Moali, C
    Mahy, F
    Rival, S
    Docquier, JD
    Rossolini, GM
    Fastrez, J
    Pratt, RF
    Frère, JM
    Galleni, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1868 - 1871
  • [10] Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily
    Bebrone, Carine
    [J]. BIOCHEMICAL PHARMACOLOGY, 2007, 74 (12) : 1686 - 1701